Elder Pharmaceuticals to enter into Japanese pharma market this fiscal

06 Dec 2011 Evaluate

After receiving accreditation from the Japanese Ministry of Health for its Patalganga facility, Elder Pharmaceuticals is planning to enter into the Japanese pharma market during the current fiscal.

The Japanese pharmaceutical market is valued at about $70 billion. The company’s planning to acquire about 1-2% of the market share.

The company is positioning itself to become a supplier of active pharmaceutical ingredients (APIs) and advanced intermediates to tap the vital Japanese market for the future growth of the company. The company’s plant at Patalganga manufactures APIs.

Elder Pharmaceuticals has also developed two products going off-patent in the Japanese market in 2014. One of the products is from the central nervous system (CNS) category and the second is from the gastrointestinal (GI) segment.


 

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×